Clinical trial
Curcumin Supplementation Effects on Markers of Cardiovascular Risk, Inflammation, Oxidative Stress and Functional Capacity in Patients With Coronary Arterial Disease
NCT04458116 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Curcumin Supplementation Effects on Markers of Cardiovascular Risk, Inflammation, Oxidative Stress and Functional Capacity in Patients With Coronary Arterial Disease
- Lead sponsor
- Universidade Federal Fluminense
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- May 10, 2021
- Completion date
- May 10, 2021
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, inflammation, oxidative stress